Overview

Study in Mild Asthmatic Patients

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and usefulness of GSK2190915 in asthmatic patients who develop asthma symptoms following being challenged.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline